PATENT CLAIM ANALYSIS

Application Number: 16070150
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["424", "133100"]

Abstract:
Methods of treating Alzheimer's Disease (AD) in patients suffering from early AD, including amyloid positive patients, ApoE4 positive patients, and patients suffering from prodromal or mild AD are provided.

Claim (Index 25):
The method of  claim 18 , wherein the agent is an anticholinergic antiparkinsonism agent selected from the group consisting of procyclidine, diphenhydramine, trihexylphenidyl, benztropine, biperiden and trihexyphenidyl.

Metadata:
- Claim Count in Document: 86.0
- Percentile: 95.0
- Lexical Diversity: 1.38462
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14283038', '14292461', '13292633', '15234649', '12738396']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.4501175523549483
- 35 USC 102 Novelty (BERT): 0.525660618306866
- Combined Prediction Score: 0.45767185895014
- Mean Citation Score: 293.24531599999995
- Max Citation Score: 302.40604
- Similarity Product: 213.27053337277889

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test